| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital S-141 86 Huddinge, Sweden
Department of Histology, Karolinska Institute S-104 01 Stockholm, Sweden
Department of Human Physiology, University of Modena 41100 Modena, Italy
Correspondence: Address requests for reprints to: Dr. Jan-Åke Gustafsson, Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital F69, S-141 86 Huddinge, Sweden.
Abstract
THE INTRACELLULAR receptor proteins for steroid hormones are a group of transcriptional regulatory proteins with several common features, acting by direct interaction with DNA. The protein must first be activated by the binding of the appropriate class of steroid. The steroid hormone receptor proteins, in particular the glucocorticoid receptor, and their role in gene regulation represent the best characterized eukaryotic gene regulating systems today, with major recent advances in knowledge of structure and function of both the protein and DNA components involved. During the 20 yr of research in this field, there are several major landmarks that have contributed to our understanding of gene regulation by steroid hormones, particularly by glucocorticoids, namely: 1) the synthesis of tritium-labeled steroids with high specific activity (1); 2) the demonstration of a high affinity, low capacity binding species, the putative receptor protein, for glucocorticoids (for review, see Refs. 2–5); 3) the interaction of the receptor with the nucleus or DNA (2–5); 4) the demonstration that glucocorticoids can regulate specific genes, their messenger RNAs (mRNAs) and their transcription (2–5); 5) the purification of the glucocorticoid-receptor complex (GR) (6–8); 6) the demonstration of specific GRbinding sequences within the genome (9); 7) the demonstration by gene transfer of glucocorticoid-responsive sequences (10); 8) the cloning of complementary DNA (cDNA) for the glucocorticoid (11–13), estrogen receptor (ER) (14–16), and progesterone (17–19) receptors (PR).
Footnotes
* This research was supported by the Swedish Medical Research Council Grant 13x-2819), the National Institutes of Health (Grant ESO 3954-02), the Bank of Sweden Tercentenary Foundation, the Ekhaga Foundation, the Funds of the Karolinska Institute, the Swedish Cancer Society, the Swedish Council for Coordination and Planning of Research, Pharmacia, and the Swedish National Board for Technical Development.
This article has been cited by other articles:
 |
|
 |
|
  L. Matthews, A. Berry, M. Tersigni, F. D'Acquisto, A. Ianaro, and D. Ray Thiazolidinediones Are Partial Agonists for the Glucocorticoid Receptor Endocrinology, January 1, 2009; 150(1): 75 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Mathew, S. Sengupta, A. Kawakami, E. A. Andreasen, C. V. Lohr, C. A. Loynes, S. A. Renshaw, R. T. Peterson, and R. L. Tanguay Unraveling Tissue Regeneration Pathways Using Chemical Genetics J. Biol. Chem., November 30, 2007; 282(48): 35202 - 35210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Lai, M. H. Wong, and C. K. C. Wong Modulation of AhR-Mediated CYP1A1 mRNA and EROD Activities by 17{beta}-Estradiol and Dexamethasone in TCDD-Induced H411E Cells Toxicol. Sci., March 1, 2004; 78(1): 41 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wu, Y. Li, J. Dietz, and D. S. Lala Repression of p65 Transcriptional Activation by the Glucocorticoid Receptor in the Absence of Receptor-Coactivator Interactions Mol. Endocrinol., January 1, 2004; 18(1): 53 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Olswang, B. Blum, H. Cassuto, H. Cohen, Y. Biberman, R. W. Hanson, and L. Reshef Glucocorticoids Repress Transcription of Phosphoenolpyruvate Carboxykinase (GTP) Gene in Adipocytes by Inhibiting Its C/EBP-mediated Activation J. Biol. Chem., April 4, 2003; 278(15): 12929 - 12936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Laugero, F. Gomez, S. Manalo, and M. F. Dallman Corticosterone Infused Intracerebroventricularly Inhibits Energy Storage and Stimulates the Hypothalamo-Pituitary Axis in Adrenalectomized Rats Drinking Sucrose Endocrinology, December 1, 2002; 143(12): 4552 - 4562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Kalman and R. L. Spencer Rapid Corticosteroid-Dependent Regulation of Mineralocorticoid Receptor Protein Expression in Rat Brain Endocrinology, November 1, 2002; 143(11): 4184 - 4195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Ziegler and J. P. Herman Neurocircuitry of Stress Integration: Anatomical Pathways Regulating the Hypothalamo-Pituitary-Adrenocortical Axis of the Rat Integr. Comp. Biol., July 1, 2002; 42(3): 541 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Greenstein, K. Ghias, N. L. Krett, and S. T. Rosen Mechanisms of Glucocorticoid-mediated Apoptosis in Hematological Malignancies Clin. Cancer Res., June 1, 2002; 8(6): 1681 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Miura, R. Ouchida, N. Yoshikawa, K. Okamoto, Y. Makino, T. Nakamura, C. Morimoto, I. Makino, and H. Tanaka Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-kappa B-dependent Transcription by Ursodeoxycholic Acid J. Biol. Chem., December 7, 2001; 276(50): 47371 - 47378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Grimm and S. K. Nordeen A Composite Enhancer Element Directing Tissue-specific Expression of Mouse Mammary Tumor Virus Requires both Ubiquitous and Tissue-restricted Factors J. Biol. Chem., April 30, 1999; 274(18): 12790 - 12796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Spencer, P. J. Kim, B. A. Kalman, and M. A. Cole Evidence for Mineralocorticoid Receptor Facilitation of Glucocorticoid Receptor-Dependent Regulation of Hypothalamic-Pituitary-Adrenal Axis Activity Endocrinology, June 1, 1998; 139(6): 2718 - 2726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. A. Leakey, J. E. Seng, C. R. Barnas, V. M. Baker, and R. W. Hart A Mechanistic Basis for the Beneficial Effects of Caloric Restriction On Longevity and Disease: Consequences for the Interpretation of Rodent Toxicity Studies International Journal of Toxicology, January 1, 1998; 17(2_suppl): 5 - 56. [Abstract] [PDF]
|
|
|
|
|
|
K. Hecht, J. Carlstedt-Duke, P. Stierna, J.-A. Gustafsson, M. Bronnegard, and A.-C. Wikstrom Evidence That the beta -Isoform of the Human Glucocorticoid Receptor Does Not Act as a Physiologically Significant Repressor J. Biol. Chem., October 17, 1997; 272(42): 26659 - 26664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Fan, J.-X. Ma, L. Cheng, and J. S. Norris Molecular Cloning of TA16, a Transcriptional Repressor That May Mediate Glucocorticoid-Induced Growth Arrest of Leiomyosarcoma Cells Mol. Endocrinol., August 1, 1997; 11(9): 1342 - 1352. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. B. Pratt and D. O. Toft Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones Endocr. Rev., June 1, 1997; 18(3): 306 - 360. [Abstract] [Full Text]
|
|
|
|
|
|
A. C. Maiyar, P. T. Phu, A. J. Huang, and G. L. Firestone Repression of Glucocorticoid Receptor Transactivation and DNA Binding of a Glucocorticoid Response Element within the Serum/Glucocorticoid-Inducible Protein Kinase (sgk) Gene Promoter by the p53 Tumor Suppressor Protein Mol. Endocrinol., March 1, 1997; 11(3): 312 - 329. [Abstract] [Full Text]
|
|
|
|
|
|
K.-I. Lee, E. P. Reddy, and C. D. Reddy Cellular Factors Binding to a Novel cis-Acting Element Mediate Steroid Hormone Responsiveness of Mouse Mammary Tumor Virus Promoter J. Biol. Chem., October 13, 1995; 270(41): 24502 - 24508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Reyes, S. Reisz-Porszasz, and O. Hankinson Identification of the Ah Receptor Nuclear Translocator Protein (Arnt) as a Component of the DNA Binding Form of the Ah Receptor Science, May 22, 1992; 256(5060): 1193 - 1195. [Abstract] [PDF]
|
|
|
|
|
|
M Orchinik, T. Murray, and F. Moore A corticosteroid receptor in neuronal membranes Science, June 28, 1991; 252(5014): 1848 - 1851. [Abstract] [PDF]
|
|
|
|
|
|
E. Hoffman, H Reyes, F. Chu, F Sander, L. Conley, B. Brooks, and O Hankinson Cloning of a factor required for activity of the Ah (dioxin) receptor Science, May 17, 1991; 252(5008): 954 - 958. [Abstract] [PDF]
|
|
|
|
|
|
T Hard, E Kellenbach, R Boelens, B. Maler, K Dahlman, L. Freedman, J Carlstedt-Duke, K. Yamamoto, J. Gustafsson, and R Kaptein Solution structure of the glucocorticoid receptor DNA-binding domain Science, July 13, 1990; 249(4965): 157 - 160. [Abstract] [PDF]
|
|
|
|
|
|
S Schwarz, P Pohl, and G. Zhou Steroid binding at sigma-"opioid" receptors Science, December 22, 1989; 246(4937): 1635 - 1637. [PDF]
|
|
|
|
|
|
D. Kerr, L. Campbell, S. Hao, and P. Landfield Corticosteroid modulation of hippocampal potentials: increased effect with aging Science, September 29, 1989; 245(4925): 1505 - 1509. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
